-
Bunnik E M, Pisas L, Van Nuenen A C. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection[J]. J Virol, 2008, 82(): 7932-7941. doi: 10.1128/JVI.00757-08
-
Buchbinder S P, Katz M H, Hessol N A. Long-term HIV-1 infection without immunological progressions[J]. AIDS, 1994, 8(): 1123-1128. doi: 10.1097/00002030-199408000-00014
-
Carotenuto P, Looij D, Keldermans L. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection[J]. AIDS, 1998, 12(13): 1591-1600. doi: 10.1097/00002030-199813000-00005
-
Cecilia D, Kleeberger C, Muñoz A. A Longitudinal Study of Neutralizing Antibodies and Disease Progression in HIV-1Infected Subjects[J]. J Infect Dis, 1999, 179(): 1365-1374. doi: 10.1086/jid.1999.179.issue-6
-
Euler Z, van Gils M J, Bunnik E M. Cross-Reactive Neutralizing Humoral Immunity Does not protect from HIV-1 type 1 disease progrssions[J]. J Infect Dis, 2010, 201(7): 1045-1053. doi: 10.1086/651173
-
Pilgrim A K, Pantaleo G, Cohen O J. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-termnon progressive infection[J]. J Infect Dis, 1996, 173(1): 60-67. doi: 10.1093/infdis/173.1.60
-
Vaine M, Wang S X, Hackett A. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity[J]. Vaccine, 2010, 28(17): 2999-3007. doi: 10.1016/j.vaccine.2010.02.006
-
Wang Z, Wang S X, Bao Z Y. Immuno genicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost"[J]. Chin Med J (Engl), 2009, 122(): 2339-2345.
-
Wei X, Decker J M, Wang S. Antibody neutralization and escape by HIV-1[J]. Nature, 2003, 422(): 307-312. doi: 10.1038/nature01470